Press Releases Grifols, S.A. Nasdaq

Equities

GRFS

US3984384087

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-15 EDT			Pre-market 07:12:05
7.69 ^USD	+2.95%		7.515	-2.28%

05-15	GRIFOLS : In line Q1 and on track deleveraging; worth a go
05-14	Grifols, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Grifols S A : on track to meet full-year guidance and reduce debt May 14 2024	05-14	PU
Grifols Q1 2024 results	05-14	AQ
Ordinary General Shareholders' Meeting	05-10	AQ
GRIFOLS, S.A. - The Board of Directors has unanimously adopted various resolutions in order to further strengthen its corporate governance system	05-08	AQ
GRIFOLS S A : The Board of Directors has unanimously adopted various resolutions in order to further strengthen its corporate governance system	05-08	PU
Grifols S A : , Haier Complete ‘Government Approval Procedures’	05-07	PU
Grifols, Haier Complete 'Government Approval Procedures'	05-07	AQ
Grifols S A : on track to close its strategic alliance with Haier in first half 2024 May 6 2024	05-06	PU
Closing of the Private Placement	04-30	AQ
Grifols Closed Private Placement Financing	04-23	AQ
Grifols S A : announces signing of private offering of EUR 1 billion senior secured notes due 2030 April 23 2024	04-23	PU
Grifols 2023 Annual Report on Form 20-F filed with the SEC	04-22	AQ
Grifols Changes Vice Secretary of the Board of Directors	04-18	AQ
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.	04-18	AQ
Grifols S A : Communications - announces the commencement of the refinancing process	04-10	PU
Clarification to the CNMV Requirements	04-05	AQ
Grifols provides responses to CNMV March 21 report	04-04	AQ
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening	04-04	GL
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening	04-04	AQ
Mr. José Ignacio (Nacho) Abia, no longer holds the category of "other external" from 1 April since he has taken on executive functions as the company's Chief Executive Officer	04-02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GRIFOLS : In line Q1 and on track deleveraging; worth a go

May 15, 2024 at 07:54 am

Gotham City sets its sights on Grifols

January 09, 2024 at 10:09 am